The most accurate and sensitive screening test available and will be transformative in tackling prostate cancer in men who may have no idea if anything is wrong with them.

Latent Labs, a pioneering AI-driven biotech startup, has secured $50 million in funding to transform how proteins are designed. Latent Labs is at the forefront of an industry shift where scientists no longer just study biology, they program it.

The UK has firmly established itself as a global innovator. With remarkable progress in bioscience advancements and bio-pharma developments, the country continues to push the limits of what’s possible in modern healthcare.

The £11 million government-funded trial, announced on World Cancer Day, will determine whether AI can analyse mammograms as accurately as human radiologists. If it proves successful, hospitals could cut their workload by 50% and speed up life-saving diagnoses.